Nuevo Vallarta, Mexico · Mexico
Research profile compiled by Stem Cell Navigator from public sources. Every fact carries a source and a verification status.
Research-backed provider profile. Each recorded fact is labelled Clinic says, Verified, Pending verification or Not disclosed, with the source we checked. Inclusion is not an endorsement and nothing here indicates that a treatment is safe or effective.
This is a research profile, not a provider listing. Stem Cell Navigator recorded what this provider publishes about itself, checked what could be checked against independent sources, and left everything else visibly unverified or not disclosed. Inclusion is not an endorsement.
Every field is asked of every provider in the same way. Where a provider has not published something, that absence is recorded rather than filled in.
Who the provider is and how an international patient reaches them.
DREAM BODY CLINIC & PHARMACEUTICALS, S.A. DE C.V.
Mexico
Nuevo Vallarta, Bahía de Banderas, Nayarit
Avenida Paseo de los Cocoteros 55, Interior 3308, Nuevo Vallarta, Bahía de Banderas, Nayarit, C.P. 63735, Mexico
https://dreambody.clinic/
Provider-reported. The provider markets the location as Puerto Vallarta / Nuevo Vallarta and describes medical-tourism logistics for international patients.
Licensing and regulatory position as claimed and as independently checked.
Provider-posted COFEPRIS sanitary licence 23-TR-18-020-0001, issued 2023-03-02, with authorisation wording for the disposition of organs, tissues and cells for therapeutic purposes, regenerative medicine modality.
COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), Mexico
Where the biologic comes from and how it is made and tested.
Allogeneic (donor-derived), as stated by the provider.
Provider-reported human umbilical-cord / Wharton's Jelly mesenchymal stem cells.
How treatment is actually administered.
Provider-reported intravenous administration plus nebulised administration for the advertised autism protocol.
Provider-reported for the advertised autism protocol: 100 million MSCs intravenously plus two nebulised sessions of 25 million MSCs. The itinerary lower on the same page instead states a 300 Million Stem Cell IV.
Clinic-stated scope only. This section never implies evidence or efficacy.
Provider-reported categories: orthopedic, autoimmune and chronic degenerative conditions, neurological conditions, and longevity / anti-aging. Autism is publicly advertised as a separate protocol.
Four deliberately separate fields. A marketing claim, a registered trial, published evidence and regulatory status are never merged.
Provider-reported. An autism protocol is publicly advertised at USD 7,500, described as 100 million MSCs intravenously plus two nebulised sessions of 25 million MSCs.
Pricing as disclosed. Absence of a published price is itself recorded.
Provider-reported USD 7,500 for the publicly advertised autism protocol.
What a travelling patient needs to plan.
Provider-reported medical-tourism logistics support for international patients travelling to Puerto Vallarta / Nuevo Vallarta. Specific transfer arrangements were not itemised on the reviewed page.
Transparency Score, Evidence Grade and verification completeness are three separate concepts and are never combined.
Published inconsistency: the advertised autism protocol states 100 million MSCs IV plus two nebulised 25 million sessions, while the itinerary further down the same page states a 300 Million Stem Cell IV. The provider has not been asked to clarify. Manufacturing laboratory, donor screening, release testing and follow-up programme are not yet recorded.
This profile records what a provider publishes about itself and what independent sources confirm. Stem Cell Navigator does not provide medical advice, diagnosis or treatment, does not endorse any provider, and a recorded claim is not evidence that a treatment works.